DBV Technologies | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amarin USD 531.38M 20.5M 2024-09
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
DBV Technologies USD 27.4M 26.63M 2024-12
Halozyme Therapeutics USD 482.27M 118.45M 2025-03
Incyte USD 3.67B 219.94M 2025-03
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
PTC Therapeutics USD -185760000 912.31M 2025-03
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
United Therapeutics USD 6.81B 363.2M 2025-03



DBV Technologies Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.